DIRECTOR / Professor - hala zreiqat

Hala Zreiqat is Professor of Biomedical Engineering, a 2016-2017 Radcliffe Fellow at Harvard University, a National Health and Medical Research Council Senior Research Fellow, Director of the ARC Training Centre for Innovative BioEngineering and is Head of the Biomaterials and Tissue Engineering Research Unit in the Faculty of Engineering at the University of Sydney. She is also an Honorary Professor at Shanghai JaioTong University (2013-2019). Her group consists of multidisciplinary team of researchers including engineers, cell and molecular biologists and clinicians. Her lab works on the development of novel engineered materials and 3D printed platforms for regenerative medicine, particularly in the fields of orthopaedics, dental and maxillofacial applications. In addition, her group is interested in the development of novel nanospheres for growth factors, drug and cell delivery as well as novel injectable materials. She has over 100 peer-reviewed publications. Her pioneering development of innovative biomaterials for tissue regeneration has led to one awarded (US) and 6 provisional patents, 5 as a lead inventor, and several collaborations with inter/national industry partners.
She is regularly invited to give keynote and plenary presentations at major international and national conferences. She has organized / chaired a number of major international conferences/ symposia / workshops. She is the immediate past president of the Australian and New Zealand Orthopaedic research Society (2010-2012). She is the founder and chair of the Alliance for Design and Application in Tissue Engineering and the IDEAL Society network. Amongst her awards are: NSW Premier’s Woman of the Year 2018, The King Abdullah II Order of Distinction of the Second Class – the highest civilian honor bestowed by the King of Jordan (2018), Leopold Dintenfass Memorial Award, for Excellence in Research (2012); University of Sydney Engineering Deans Research Award (2009).

dEPUTY DIRECTOR / Professor - Colin Dunstan

Associate Professor Colin Dunstan is a respected authority on bone metabolism with over 25 years of experience in both clinical and basic research. He was part of the team that identified osteoprotegerin, RANK ligand and RANK as central regulators of bone resorption. He has extensive experience in both academic and industry (Amgen) settings. He currently serves on the editorial boards of Endocrinology and the Journal of Bone and Mineral Research. Current research interests are in the local regulation of bone remodelling and in interactions between bone cell activity and cancer cells.

CO-dEPUTY DIRECTOR / dr - Jiao jiao lI

Dr Jiao Jiao Li (JJ) is a biomedical engineer, NHMRC Early Career Fellow, and a chief investigator on the ARC Training Centre for Innovative BioEngineering. She received her PhD from the University of Sydney in 2015. JJ is researching regenerative medicine approaches to treat chronic musculoskeletal conditions such as osteoarthritis and bone loss. She has particular interest in developing stem cell-based therapeutics, as well as biomaterials for tissue engineering.

assistant dEPUTY DIRECTOR / dr - ashnil kumar

Dr Ashnil Kumar received his PhD from the University of Sydney in 2013. He is currently a lecturer in the School of Biomedical Engineering conducting research into computing algorithms and their application within clinical workflows. He is particularly interested in how to design and develop decision support systems that enhance clinicians’ decision making capacity. He works closely with clinicians from a number of hospitals in Sydney, including the Royal Prince Alfred Hospital, Westmead Hospital and Nepean Hospital.


Mrs. Ros Wu joined the ARCTCIBE in June 2020 as the manager of the centre. She has previously obtained MCom and MEng.  



Professor Fiona Wood is one of Australia’s most innovative and respected surgeons and researchers. A highly skilled plastic and reconstructive surgeon and world leading burns specialist, she has pioneered research and technology development in burns medicine.

One of Fiona’s early achievements was the development of a skin culture lab that she co-founded with scientist Marie Stoner. Professor Wood and Marie recognised the potential of tissue engineering technology to treat burns (called cultural epithelial autograph or CEA) and in 1993 developed a skin culture facility with support from a Telethon grant. Their product evolved from confluent sheets of CEA to aerosol-delivered cell-clusters, and is known as ‘spray-on skin’. This technology, commercialized through Clinical Cell Culture Pty Ltd (now AvitaMedical) is a world-first and has been used on more than 1000 patients around the world. In 2005 Professor Wood and Marie won the Clunies Ross Award (Australian Academy of Technological Sciences and Engineering for their contribution to medical science in Australia.

PROFESSOR - chris little

Professor Christopher Little is director of the Raymond Purves Bone and Joint Research Labs at the Kolling Institute of Medical Research at Royal North Shore Hospital, Australia. Chris is a qualified Veterinarian with specialist surgery training and ACVS certification. He was awarded a PhD degree from the University of Sydney in 1996 for his studies of cartilage degradation in a sheep model of osteoarthritis (OA). Following a 5-year postdoctoral position at Cardiff University (UK), he was awarded an Arthritis Foundation of Australia Fellowship at the University of Melbourne. In 2004 he moved to his current position in the University of Sydney Faculty of Medicine. Chris’s research interests focus on defining the biochemical and molecular mechanisms of joint pathology in OA, and tendon and intervertebral disc degeneration, and are based on the belief that it is only though a better understanding the mechanisms that drive the initiation and progression of these diseases that new therapies can be developed. Chris is recognized internationally for his expertise in the development and use of animal models of bone and joint disease. He has served as an Associate Editor of Osteoarthritis and Cartilage, and a leader of the OARSI international initiative to establish standardised methods for evaluation of animal models of OA. Chris received the 2010 Barry Preston Award from the Matrix Biology Society of Australia and New Zealand, presented to an outstanding leader in the field.

A/Professor -Yi-chin toh

Yi-Chin Toh is a Future Fellow and Associate Professor at the Queensland University of Technology. She obtained her B.Eng in Chemical Engineering and Ph.D in Bioengineering from the National University of Singapore in 2001 and 2008 respectively. She did her post-doctoral training at the Massachusetts Institute of Technology in 2008 under Professor Joel Voldman’s guidance. Before joining QUT, she was an Assistant Professor at the Department of Biomedical Engineering, National University of Singapore.

Yi-Chin leads the Micro Tissue Engineering Lab ( Her major scientific contribution is in the advancement of microfluidic tissue models for applications in drug testing and experimental biology. To date, she has published over 40 papers in leading scientific journals such as Biomaterials and Lab on a Chip. Her current research interest is in engineering multi-scale tissue models to mimic complex biological interactions during human development and diseases, as well as translating them into scalable platforms for disease modeling and drug testing applications. Her lab is also working on integrating microfluidics and biofabrication technologies to realise a new generation of human-on-chips. Dr Toh is a recipient of the Australia Research Council Future Fellowship, National University of Singapore Research Scholarship, A*STAR Graduate Scholarship and A*STAR International Fellowship.

dr. - Mate biro

Dr Maté Biro received his PhD with summa cum laude at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany. 

Dr. Biro has previously worked at the Centenary Institute of Cancer Medicine and Cell Biology in Sydney, in the Imaging Informatics division at the Bioinformatics Institute of A*STAR in Singapore, at the MIT BioImaging Center in Cambridge, MA, USA and in the Belle collaboration at the KEK: High Energy Accelerator Research Organisation in Tsukuba, Japan.

As an EMBL Australia Group Leader he will expand his exciting studies on the way actomyosin complexes control cell shape, homeostasis and migration in cancer and immune function, focusing on the elucidation of biomechanical interaction within and between cells.

Dr. Biro is spearheading the use of complex in vitro and in vivo models for studying the cell-intrinsic actin cytoskeleton cues and dynamics that govern the invasive migration of tumour cells, the tissue scanning of T cells and their cytotoxic interaction with tumour cells. Using a multidisciplinary approach encompassing cell biology, biophysics, bioimage informatics and advanced light microscopy, he aims to unravel fundamental actin-based processes and develop new methodologies for basic cell biological research. Dr. Biro’s research relies heavily on advanced microscopy and the development of image analysis platforms capable of automatically detecting and analysing the kinetics of actomyosin, cell movement and protrusions.

Dr. Biro’s group is primarily concerned with the cell biology and mechanics of the actin cytoskeleton, and how immune cells (T cells) locate and kill cancer cells.

Professor - hala zreiqat

See Above

Professor - Colin Dunstan

See Above


Professor - hala zreiqat

See Above

Professor - Colin Dunstan

See Above

Dr - Shanny Dyer

Dr. Shanny is an experienced senior executive, having held roles across industry, government and universities. She has expertise in public administration and policy development with strong corporate governance skills. Shanny holds a PhD in Biochemistry and is a graduate of the Australian Institute of Company Directors. She is the CEO of ARCS Australia.

Dr - William lu

Dr. William Lu is the postdoctoral researcher at Osseintegration Group of Australia

Dr - Warren Smith

Dr. Smith is the advanced technologies manager at Ti2 Medical Pty Ltd.

Professor - Michael Fulham

Professor Fulham is the clinical director of Medical Imaging/ Director Department of Neurologist at RPA and the University of Sydney


A/Professor - Jinman Kim

Associate Professor Jinman Kim received his PhD in Computer Science from the University of Sydney in 2005. He is currently the Director of the Visual TeleHealth Lab, the Biomedical & Multimedia Information Technology (BMIT) Research Group , School of Computer Science, Faculty of Engineering and Information Technologies, University of Sydney. As an active key member of the BMIT Research Group, he is in charge of a research commercialisation and industry links. He has produced a number of impact publications, including IEEE Transactions, Medical Image Analysis, etc., and received several prestigious external completive grants, including the ARC Discovery and Linkage grants. He is also a Theme Leader in the Faculty’s Institute of Biomedical Engineering and Technologies (BMET).

Mr - robert bell

Head:Technology & Innovation, Allegra Orthopaedics Ltd

Mr - mark kay

Mr. Mark Kay is a Director, Post Award Research at University of Sydney

dr - Fiona Cameron

Dr Fiona Cameron joined the ARC in July 2012 as Executive Director for Biological Sciences and Biotechnology. Prior to this, Dr Cameron led the Innovation & Consulting Unit at the University of Western Sydney (UWS) as the Associate Director. In this role, she worked closely with the University Executive, academics, active researchers and the University Research Office at UWS to identify opportunities to protect, develop and commercialise Intellectual Property and to build relationships with Industry and Government.

Between 1986 and 2007 Dr Cameron worked at the CSIRO, where she was appointed a Principal Research Scientist of its Division of Molecular Science, and a member of the executive team of the CSIRO National Research Food Futures Flagship. Dr Cameron was also a key developer of the CSIRO Nanotechnology Centre. Active in gene control research, Dr Cameron’s work at CSIRO included the development of molecules for better gene delivery into cells and gene therapy.

Being heavily involved in commercially funded medical research, Dr Cameron’s most recent publications take the form of a suite of patents.

Dr Cameron originally trained at the University of Sydney and the Australian National University. She was awarded a Doctor of Philosophy in 1990 from Macquarie University, having studied the regulation of gene control using engineered ribonucleic acids.

Tel: 0061 2 9114 4607



@2020 ARC Centre for Innovative BioEngineering

Level 4, J07
Faculty of Mechanical Engineering
University of Sydney
Darlington NSW 2008